Vbi Vaccines Inc buy stratec
Start price
10.11.17
/
50%
?3.72
Target price
23.10.18
€5.86
Performance (%)
-48.54%
End price
23.10.18
€1.91
Summary
This prediction ended on 23.10.18 with a price of €1.91. Massive losses of -48.54% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vbi Vaccines Inc | - | - | - | - |
iShares Core DAX® | -3.935% | -2.628% | 10.013% | 11.951% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% | 35.711% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% | 2.602% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% | 37.820% |
Comments by stratec for this prediction
In the thread Vbi Vaccines Inc diskutieren
stratec stimmt der Buy-Einschätzung von marge zu
stratec stimmt am 10.11.2017 der Buy-Einschätzung von marge mit dem Kursziel 6,5$ zu.Überschrift: VBIV continues making progress towards starting a Phase 3 trial for hepatitis B
(Laufzeit überschritten)